Jaggi Ophthalmic

Executive Summary

Jaggi Ophthalmic (Jaggi Brothers) is a private Indian med-tech company established in 1994, specializing in the distribution and support of premium ophthalmic diagnostic and surgical equipment. Through strategic partnerships with overseas manufacturers like Huvitz (South Korea) and Chinese OEMs, the company offers a comprehensive portfolio including OCT, optical biometers, fundus cameras, slit-lamp microscopes, autorefractometers, and keratometers. Serving eye hospitals, clinics, and optometry centers across India, Jaggi focuses on enhancing diagnosis and treatment of cataract, glaucoma, and retinal diseases with high-quality, internationally certified devices. The company is commercially active and privately held, with no disclosed funding rounds or valuation. Given its long-standing presence and established distribution network, Jaggi is well-positioned to benefit from India's growing ophthalmic device market, driven by increasing prevalence of eye disorders and rising healthcare expenditure. However, as a private company, transparency on financial performance and strategic initiatives is limited. The conviction score reflects a balanced view of its stable market position versus limited public data.

Upcoming Catalysts (preview)

• Q2 2026New OEM partnership for advanced diagnostic devices65% success
• Q3 2026Expansion into tier-2 and tier-3 cities in India70% success
• Q4 2026Launch of a new AI-integrated ophthalmic platform40% success